Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis

Objectives. This study aimed to demonstrate if the addition of anti-inflammatory treatment to antibiotic therapy shows any superiority to the treatment with antibiotic only. Methods. Forty-nine Wistar rats were divided into 7 groups. Pyelonephritis was performed by E. coli injection to upper pole of...

Full description

Bibliographic Details
Main Authors: Elif Bahat Özdoğan, Tuğba Özdemir, Seçil Arslansoyu Çamlar, Mustafa İmamoğlu, Ümit Çobanoğlu, Bircan Sönmez, İlknur Tosun, İsmail Doğan
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/134940
id doaj-c41f88bb633e41ecadffdb53a16307dc
record_format Article
spelling doaj-c41f88bb633e41ecadffdb53a16307dc2020-11-24T21:35:11ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/134940134940Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute PyelonephritisElif Bahat Özdoğan0Tuğba Özdemir1Seçil Arslansoyu Çamlar2Mustafa İmamoğlu3Ümit Çobanoğlu4Bircan Sönmez5İlknur Tosun6İsmail Doğan7Department of Pediatrics, Division of Pediatric Nephrology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Pediatrics, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Pediatrics, Division of Pediatric Nephrology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Pediatric Surgery, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Pathology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Nuclear Medicine, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyDepartment of Nuclear Medicine, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, TurkeyObjectives. This study aimed to demonstrate if the addition of anti-inflammatory treatment to antibiotic therapy shows any superiority to the treatment with antibiotic only. Methods. Forty-nine Wistar rats were divided into 7 groups. Pyelonephritis was performed by E. coli injection to upper pole of kidneys except control group. Group 2 was not treated. Ceftriaxone, ketoprofen, “ceftriaxone + ketoprofen,” methylprednisolone, and “ceftriaxone + methylprednisolone” were given in the groups. The technetium-99m-dimercaptosuccinic acid scintigraphies were performed in 3rd day to detect pyelonephritis and 10th week to detect renal scarring. All kidneys were also histopathologically evaluated. Results. When 3rd day and 10th week scintigraphies were compared, initial 2.00 ± 0.30 point pyelonephritis score resulted in 0.71 ± 0.36 renal scar score in “ceftriaxone + ketoprofen” group (P=0.039). Initial 2.00 ± 0.43 point pyelonephritis score resulted in 0.86 ± 0.26 renal scar score in “ceftriaxone + methylprednisolone” group (P=0.041). Renal scar score was declined in “ceftriaxone + ketoprofen” group and “ceftriaxone + methylprednisolone” group compared with no-treatment group on 10th week of the study (P=0.026, P=0.044). On histopathological evaluation, it was seen that renal scar prevalence and expansion declined significantly in “ceftriaxone + ketoprofen and ceftriaxone + methylprednisolone” (P=0.011, P=0.023). Conclusion. It was evidenced that ceftriaxone treatment in combination with ketoprofen or methylprednisolone declined scar formation in scintigraphic and histopathologic examinations of the kidneys.http://dx.doi.org/10.1155/2014/134940
collection DOAJ
language English
format Article
sources DOAJ
author Elif Bahat Özdoğan
Tuğba Özdemir
Seçil Arslansoyu Çamlar
Mustafa İmamoğlu
Ümit Çobanoğlu
Bircan Sönmez
İlknur Tosun
İsmail Doğan
spellingShingle Elif Bahat Özdoğan
Tuğba Özdemir
Seçil Arslansoyu Çamlar
Mustafa İmamoğlu
Ümit Çobanoğlu
Bircan Sönmez
İlknur Tosun
İsmail Doğan
Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
BioMed Research International
author_facet Elif Bahat Özdoğan
Tuğba Özdemir
Seçil Arslansoyu Çamlar
Mustafa İmamoğlu
Ümit Çobanoğlu
Bircan Sönmez
İlknur Tosun
İsmail Doğan
author_sort Elif Bahat Özdoğan
title Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
title_short Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
title_full Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
title_fullStr Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
title_full_unstemmed Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
title_sort could pyelonephritic scarring be prevented by anti-inflammatory treatment? an experimental model of acute pyelonephritis
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2014-01-01
description Objectives. This study aimed to demonstrate if the addition of anti-inflammatory treatment to antibiotic therapy shows any superiority to the treatment with antibiotic only. Methods. Forty-nine Wistar rats were divided into 7 groups. Pyelonephritis was performed by E. coli injection to upper pole of kidneys except control group. Group 2 was not treated. Ceftriaxone, ketoprofen, “ceftriaxone + ketoprofen,” methylprednisolone, and “ceftriaxone + methylprednisolone” were given in the groups. The technetium-99m-dimercaptosuccinic acid scintigraphies were performed in 3rd day to detect pyelonephritis and 10th week to detect renal scarring. All kidneys were also histopathologically evaluated. Results. When 3rd day and 10th week scintigraphies were compared, initial 2.00 ± 0.30 point pyelonephritis score resulted in 0.71 ± 0.36 renal scar score in “ceftriaxone + ketoprofen” group (P=0.039). Initial 2.00 ± 0.43 point pyelonephritis score resulted in 0.86 ± 0.26 renal scar score in “ceftriaxone + methylprednisolone” group (P=0.041). Renal scar score was declined in “ceftriaxone + ketoprofen” group and “ceftriaxone + methylprednisolone” group compared with no-treatment group on 10th week of the study (P=0.026, P=0.044). On histopathological evaluation, it was seen that renal scar prevalence and expansion declined significantly in “ceftriaxone + ketoprofen and ceftriaxone + methylprednisolone” (P=0.011, P=0.023). Conclusion. It was evidenced that ceftriaxone treatment in combination with ketoprofen or methylprednisolone declined scar formation in scintigraphic and histopathologic examinations of the kidneys.
url http://dx.doi.org/10.1155/2014/134940
work_keys_str_mv AT elifbahatozdogan couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT tugbaozdemir couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT secilarslansoyucamlar couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT mustafaimamoglu couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT umitcobanoglu couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT bircansonmez couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT ilknurtosun couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
AT ismaildogan couldpyelonephriticscarringbepreventedbyantiinflammatorytreatmentanexperimentalmodelofacutepyelonephritis
_version_ 1725946183824703488